Vivian Tsai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Vivian Tsai has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Jeptha Curtis
3 shared publications- Paul A. Heidenreich
Medical Service, VA Palo Alto Healthcare System, CA (R.L.T., N.M.K., A.V., N.D., A.S., P.H.).
3 shared publications Henry H. Hsia
From the Stanford University School of Medicine, Stanford, CA (V.T., M.K.G., H.H.H., P.A.H.); VA Palo Alto Health Care System, Palo Alto, CA (M.K.G., P.A.H.); and Yale University, New Haven, CT (Y.W., J.C.).
2 shared publicationsMary K. Goldstein
From the Stanford University School of Medicine, Stanford, CA (V.T., M.K.G., H.H.H., P.A.H.); VA Palo Alto Health Care System, Palo Alto, CA (M.K.G., P.A.H.); and Yale University, New Haven, CT (Y.W., J.C.).
2 shared publicationsYongfei Wang
From the Stanford University School of Medicine, Stanford, CA (V.T., M.K.G., H.H.H., P.A.H.); VA Palo Alto Health Care System, Palo Alto, CA (M.K.G., P.A.H.); and Yale University, New Haven, CT (Y.W., J.C.).
2 shared publicationsAdrian Hernandez
1 shared publication
Latest Publications
- 1 September 2011
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 4 (5) , 549-556
Influence of Age on Perioperative Complications Among Patients Undergoing Implantable Cardioverter-Defibrillators for Primary Prevention in the United States
Background—: The majority of current implantable cardioverter-defibrillator (ICD) recipients are significantly older than those in the ICD trials. Data on periprocedural complications among the elderly are insufficient. We evaluated the influence of age on perioperative complications among primary prevention ICD recipients in the United States. Methods and Results—: Using the National Cardiovascular Data's ICD Registry, we identified 150 264 primary prevention patients who received ICDs from January 2006 to December 2008. The primary end point was any adverse event or in-hospital mortality. Secondary end points included major adverse events, minor adverse events, and length of stay. Of 150 264 patients, 61% (n=91 863) were 65 years and older. A higher proportion of patients ≥65 years had diabetes, congestive heart failure, atrial fibrillation, renal disease, and coronary artery disease. Approximately 3.4% of the entire cohort had any complication, including death, after ICD implant. Any adverse event or death occurred in 2.8% of patients under 65 years old; 3.1% of 65- to 69-year-olds; 3.5% of 70- to 74-year-olds; 3.9% of 75- to 79-year-olds, 4.5% of 80- to 84-year-olds; and 4.5% of patients 85 years and older. After adjustment for clinical covariates, multivariate analysis found an increased odds of any adverse event or death among 75- to 79-year-olds (1.14 [95% confidence interval, 1.03 to 1.25], 80-to 84-year-olds (1.22 [95% confidence interval, 1.10 to 1.36], and patients 85 years and older (1.15 [95% confidence interval, 1.01 to 1.32], compared with patients under 65 years old. Conclusions—: Older patients had a modestly increased—but acceptably safe—risk of periprocedural complications and in-hospital mortality, driven mostly by increased comorbidity.
- 1 September 2011
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 4 (5) , 549-556
Influence of Age on Perioperative Complications Among Patients Undergoing Implantable Cardioverter-Defibrillators for Primary Prevention in the United States
Background—: The majority of current implantable cardioverter-defibrillator (ICD) recipients are significantly older than those in the ICD trials. Data on periprocedural complications among the elderly are insufficient. We evaluated the influence of age on perioperative complications among primary prevention ICD recipients in the United States. Methods and Results—: Using the National Cardiovascular Data's ICD Registry, we identified 150 264 primary prevention patients who received ICDs from January 2006 to December 2008. The primary end point was any adverse event or in-hospital mortality. Secondary end points included major adverse events, minor adverse events, and length of stay. Of 150 264 patients, 61% (n=91 863) were 65 years and older. A higher proportion of patients ≥65 years had diabetes, congestive heart failure, atrial fibrillation, renal disease, and coronary artery disease. Approximately 3.4% of the entire cohort had any complication, including death, after ICD implant. Any adverse event or death occurred in 2.8% of patients under 65 years old; 3.1% of 65- to 69-year-olds; 3.5% of 70- to 74-year-olds; 3.9% of 75- to 79-year-olds, 4.5% of 80- to 84-year-olds; and 4.5% of patients 85 years and older. After adjustment for clinical covariates, multivariate analysis found an increased odds of any adverse event or death among 75- to 79-year-olds (1.14 [95% confidence interval, 1.03 to 1.25], 80-to 84-year-olds (1.22 [95% confidence interval, 1.10 to 1.36], and patients 85 years and older (1.15 [95% confidence interval, 1.01 to 1.32], compared with patients under 65 years old. Conclusions—: Older patients had a modestly increased—but acceptably safe—risk of periprocedural complications and in-hospital mortality, driven mostly by increased comorbidity.
- 24 August 2011
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 59 (9) , 1589-1595
Age Differences in Primary Prevention Implantable Cardioverter‐Defibrillator Use in U.S. Individuals
OBJECTIVES: To estimate the potentially inappropriate use of implantable cardioverter‐defibrillator ICDs in older U.S. adults. DESIGN: Retrospective study. SETTING: The National Cardiovascular Data ICD Registry. PARTICIPANTS: Forty‐four thousand eight hundred five individuals in the National Cardiovascular Data's ICD Registry ™ who had received ICDs for primary prevention from January 2006 to December 2008. Individuals with a prior myocardial infarction and ejection fraction less than 30% were included. MEASUREMENTS: Mortality risk was categorized using the Multicenter Automatic Defibrillator Implantation (MADIT) II risk‐stratification system. Low‐risk and very‐high‐risk individuals were considered potentially inappropriate recipients. RESULTS: Of 44,805 individuals, 67% (n=29,893) were aged 65 and older, of whom 51% were aged 75 and older. A significant proportion of ICD recipients had a low risk of death (16%, n=6,969) or very high risk of nonarrhythmic death (8%, n=3,693). Potentially inappropriate ICD use was 10% in those aged 75 and older, much less than in younger groups (40%, P <.001). Although age was associated with a high risk of nonarrhythmic death, its influence was markedly attenuated after adjusting for comorbidities and timing of ICD implantation (odds ratio=1.02, 95% confidence interval=1.02–1.03, P <.001). CONCLUSION: Potentially inappropriate ICD use appears significantly less—and at modest rates—in older Americans than in younger age groups. Overall, almost one‐quarter of individuals may have received ICDs inappropriately based on their risk of death. Physicians appear to be conservatively referring older adults and wisely deferring those with high comorbid burden.
- 24 August 2011
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 59 (9) , 1589-1595
Age Differences in Primary Prevention Implantable Cardioverter‐Defibrillator Use in U.S. Individuals
OBJECTIVES: To estimate the potentially inappropriate use of implantable cardioverter‐defibrillator ICDs in older U.S. adults. DESIGN: Retrospective study. SETTING: The National Cardiovascular Data ICD Registry. PARTICIPANTS: Forty‐four thousand eight hundred five individuals in the National Cardiovascular Data's ICD Registry ™ who had received ICDs for primary prevention from January 2006 to December 2008. Individuals with a prior myocardial infarction and ejection fraction less than 30% were included. MEASUREMENTS: Mortality risk was categorized using the Multicenter Automatic Defibrillator Implantation (MADIT) II risk‐stratification system. Low‐risk and very‐high‐risk individuals were considered potentially inappropriate recipients. RESULTS: Of 44,805 individuals, 67% (n=29,893) were aged 65 and older, of whom 51% were aged 75 and older. A significant proportion of ICD recipients had a low risk of death (16%, n=6,969) or very high risk of nonarrhythmic death (8%, n=3,693). Potentially inappropriate ICD use was 10% in those aged 75 and older, much less than in younger groups (40%, P <.001). Although age was associated with a high risk of nonarrhythmic death, its influence was markedly attenuated after adjusting for comorbidities and timing of ICD implantation (odds ratio=1.02, 95% confidence interval=1.02–1.03, P <.001). CONCLUSION: Potentially inappropriate ICD use appears significantly less—and at modest rates—in older Americans than in younger age groups. Overall, almost one‐quarter of individuals may have received ICDs inappropriately based on their risk of death. Physicians appear to be conservatively referring older adults and wisely deferring those with high comorbid burden.